1. Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network. Issue 6 (3rd February 2016) Authors: Younossi, Z. M.; Bacon, B. R.; Dieterich, D. T.; Flamm, S. L.; Kowdley, K.; Milligan, S.; Tsai, N.; Nezam, A. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 6(2016) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase. (February 2020) Authors: Gerussi, A.; Bernasconi, D.; O'donnell, S.E.; Lammers, W.J.; Van Buuren, H.; Hirschfield, G.; Janssen, H.; Corpechot, C.; Reig, A.; Pares, A.; Battezzati, P.M.; Zuin, M.G.; Cazzagon, N.; Floreani, A.; Nevens, F.; Gatselis, N.; Dalekos, G.; Mayo, M.J.; Thorburn, D.; Bruns, T. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗